Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-07-19
2011-07-19
Wang, Chang-Yu (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S001100, C514S001200, C514S001300, C514S007600, C514S017700, C435S368000
Reexamination Certificate
active
07981863
ABSTRACT:
The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells. These methods are useful for reducing at least one symptom of the disorder.
REFERENCES:
patent: 5116873 (1992-05-01), Gorio et al.
patent: 5219759 (1993-06-01), Heldin et al.
patent: 5653975 (1997-08-01), Baetge et al.
patent: 5980885 (1999-11-01), Weiss et al.
patent: 6040157 (2000-03-01), Hu et al.
patent: 6071889 (2000-06-01), Weiss et al.
patent: 6165783 (2000-12-01), Weiss et al.
patent: 6294346 (2001-09-01), Weiss et al.
patent: 6497872 (2002-12-01), Weiss et al.
patent: 2002/0197238 (2002-12-01), Weiss et al.
patent: 2002308471 (2002-11-01), None
patent: 1 132 098 (2001-09-01), None
patent: WO 93/10806 (1993-06-01), None
patent: WO 99/37751 (1999-07-01), None
patent: WO 99/47677 (1999-09-01), None
patent: WO 01/12236 (2001-02-01), None
patent: WO 01/49849 (2001-07-01), None
patent: WO 01/76620 (2001-10-01), None
patent: WO 02/088330 (2002-11-01), None
Knight et al. Am J. Surg. 1998. 176: 55S-60S.
Maysinger et al. Trends Biotechnol. Oct. 1997;15(10):410-8.
Kawabe et al. Neurosci. Res. 1997. 29: 335-343.
Abboud et al. (1994).J. Cellular Physiology158: 140-150.
Chiu et al. (1984).Cell37: 123-129.
Collins et al. (1985).Nature316: 748-750.
Dvorak et al. (1995).American J. Pathology146: 1029-1039.
Folkman, Judah (1995).Nature Medicine1: 27-31.
Freed et al. (2001).N. Engl. J. Med.344: 710-719.
Gould et al. (2000).Biol. Psychiatry48: 715-720.
Grinspan et al. (1994).Annals of Neurology36 Supp: S140-S142.
Johansson et al. (1999).Experimental Cell Res.253: 733-736.
Johe et al. (1996).Genes&Development10: 3129-3140.
Johnsson et al. (1984).EMBO J.3: 921-928.
Kwon, Yunhee Kim (2002).J. Biochem. and Mol. Biol.35: 87-93.
Maglione et al. (1991).Proc. Nall. Acad. Sci. USA88: 9267-9271.
Nakayama, Kazuhisa (1997).Biochem. J.327: 625-635.
Ostman et al. (1992).J. Cell Biol.118: 509-519.
Piccini et al. (2000).Annals of Neurology48: 689-695.
Soker et al. (1998).Cell92: 735-745.
Takagi et al. (1991).Neuron7: 295-307.
Thomas, Kenneth (1996).J. Biol. Chem.271: 603-606.
Valenzuela et al. (1997).Brain Res. Rev.24: 77-89.
Williams et al. (1997).Neuron18: 553-562.
International Search Report for PCT/IB02/03998, mailed Feb. 10, 2003.
Nikkhah et al., “Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture”,Exp. Brain Res., 92:516-523 (1993).
Erlandsson et al. “Immature Neurons From CNS Stem Cells Proliferate in Response to Platelet-Derived Growth Factor.” The Journal of Neuroscience, May 15, 2001, 21(10): 3483-3491.
Jin et al., “Vascular Endothelial Growth Factor Rescues HN33 Neural Cells from Death Induced by Serum Withdrawal”,Journal of Molecular Neuroscience, 14:197-203 (2000).
Oosthuyse et al., “Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration”,Nature Genetics, 28:131-138 (2001).
Delfani Kioumars
Janson Ann Marie
Kuhn H. Georg
Plate Karlheinz
Schanzer Anne
Elrifi Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Neuronova AB
Pavao Matthew
Wang Chang-Yu
LandOfFree
Treatment of Parkinson's disease with PDGF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of Parkinson's disease with PDGF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of Parkinson's disease with PDGF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666505